In the current trading session, Biodexa Pharmaceuticals Plc ADR’s (BDRX) stock is trading at the price of $1.70, a gain of 97.93% over last night’s close. So, the stock is trading at a price that is -97.42% less than its 52-week high of $66.00 and 136.37% better than its 52-week low of $0.72. Based on the past 30-day period, the stock price is -22.46% below the high and +115.61% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, BDRX’s SMA-200 is $3.6769.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
It is also essential to consider BDRX stock ratios like the price-to-sales ratio, which is 0.64 for the last year.BDRX’s price to book ratio for the most recent quarter was 3.37, resulting in an 0.06 price to cash per share for the period.
How does Biodexa Pharmaceuticals Plc ADR (BDRX) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.
Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) Ownership Details
I will give a breakdown of the key shareholders in Biodexa Pharmaceuticals Plc ADR (BDRX). Recent figures show that the company’s insiders hold 16.64% of shares. A total of 14 institutional investors hold shares in the company, making 31.32% of its stock and 37.57% of its float.
Dec 30, 2023, it was reported that the Company’s largest institutional holder is Boothbay Fund Management, LLC holding total of 44593.0 shares that make 18.85% of the company’s total number of shares and are currently priced at 71794.0.
The securities firm Renaissance Technologies, LLC holds 11700.0 shares of BDRX, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 4.95%, and the holding percentage of shares is valued at 18837.0.
An overview of Biodexa Pharmaceuticals Plc ADR’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Biodexa Pharmaceuticals Plc ADR (BDRX) traded 3,112,554 shares per day, with a moving average of $1.1755 and price change of +0.2809. With the moving average of $1.4290 and a price change of -0.2791, about 1,934,210 shares changed hands on average over the past 50 days. Finally, BDRX’s 100-day average volume is 1,372,937 shares, alongside a moving average of $2.1083 and a price change of -2.2891.
